Protein kinase C-mediated regulation of the cell cycle

被引:147
作者
Black, JD [1 ]
机构
[1] Roswell Pk Canc Inst, Dept Pharmacol & Therapeut, Buffalo, NY 14263 USA
来源
FRONTIERS IN BIOSCIENCE-LANDMARK | 2000年 / 5卷
关键词
PKC; cell cycle; cell growth; p21(waf1/cip1); G(1) to S transition; G(2) to M transition; cell cycle exit; intestinal epithelium; colon carcinogenesis; review;
D O I
10.2741/Black
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Members of the protein kinase C (PKC) family of signal transduction molecules have been widely implicated in regulation of cell growth/cell cycle progression and differentiation. Increasing evidence from studies using in vitro and in vivo systems points to PKC as a key regulator of critical cell cycle transitions, including cell cycle entry and exit and the G(1) and G(2) checkpoints. PKC-mediated control of these transitions can be negative or positive, depending on the timing of PKC activation during the cell cycle and on the specific PKC isozymes involved. Most of the mechanistic information available relates to the involvement of this enzyme family in negative regulation of these transitions. Accumulating data indicate that a major target for PKC-mediated inhibition of cell cycle progression is the Cip/Kip cyclin-dependent kinase (cdk) inhibitor p21(waf1/cip1). Increased expression of p21(waf1/cip1) blocks cdk2 activity in G(1) phase, leading to hypophosphorylation of the retinoblastoma protein and inhibition of cell cycle progression into S phase. In G(2), p21(waf1/cip1) expression blocks cdc2/cyclin B activity, likely through an indirect mechanism involving inhibition of the cdk2/cyclin A complex, and prevents progression into M phase. PKC signaling can also activate a coordinated program of pocket protein regulation leading to cell cycle withdrawal into G(0). The molecular events underlying positive regulation of cell cycle progression by PKC signaling remain poorly understood, although there is evidence for a role of the enzyme in promoting G(2)-->M progression by phosphorylating lamin B at sites involved in nuclear lamina disassembly. Understanding of the mechanisms underlying PKC-mediated control of the cell cycle is beginning to provide important insight into its role in uncontrolled cell growth and transformation.
引用
收藏
页码:D406 / D423
页数:18
相关论文
共 156 条
[1]   Protein kinase C α modulates growth and differentiation in Caco-2 cells [J].
Abraham, C ;
Scaglione-Sewell, B ;
Skarosi, SF ;
Qin, WY ;
Bissonnette, M ;
Brasitus, TA .
GASTROENTEROLOGY, 1998, 114 (03) :503-509
[2]   p21WAF1 expression by an activator of protein kinase C is regulated mainly at the post-transcriptional level in cells lacking p53:: important role of RNA stabilization [J].
Akashi, M ;
Osawa, Y ;
Koeffler, HP ;
Hachiya, M .
BIOCHEMICAL JOURNAL, 1999, 337 :607-616
[3]   Regulation of the cell cycle at the G2/M boundary in metastatic melanoma cells by 12-O-tetradecanoyl phorbol-13-acetate (TPA) by blocking p34cdc2 kinase activity [J].
Arita, Y ;
Buffolino, P ;
Coppock, DL .
EXPERIMENTAL CELL RESEARCH, 1998, 242 (02) :381-390
[4]   METABOLIC-RATE OF MEMBRANE-PERMEANT DIACYLGLYCEROL AND ITS RELATION TO HUMAN RESTING LYMPHOCYTE-T ACTIVATION [J].
ASAOKA, Y ;
OKA, M ;
YOSHIDA, K ;
NISHIZUKA, Y .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1991, 88 (19) :8681-8685
[5]   PROTEIN-KINASE-C, CALCIUM AND PHOSPHOLIPID DEGRADATION [J].
ASAOKA, Y ;
NAKAMURA, S ;
YOSHIDA, K ;
NISHIZUKA, Y .
TRENDS IN BIOCHEMICAL SCIENCES, 1992, 17 (10) :414-417
[6]  
ASAOKA Y, 1992, CIBA F SYMP, V164, P50
[7]  
ASAOKA Y, 1992, J NUTR SCI VITAMINOL, P7
[8]   Protein kinase cδ inhibition of S-phase transition in capillary endothelial cells involves the cyclin-dependent kinase inhibitor p27Kip1 [J].
Ashton, AW ;
Watanabe, G ;
Albanese, C ;
Harrington, EO ;
Ware, JA ;
Pestell, RG .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1999, 274 (30) :20805-20811
[9]  
ASIEDU C, 1995, CANCER RES, V55, P3716
[10]   Complex regulation of CDK2 during phorbol ester-induced hematopoietic differentiation [J].
Asiedu, C ;
Biggs, J ;
Kraft, AS .
BLOOD, 1997, 90 (09) :3430-3437